A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure
Open Access
- 31 March 2007
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 153 (5) , 868-873
- https://doi.org/10.1016/j.ahj.2007.02.024
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Depression in Heart FailureJournal of the American College of Cardiology, 2006
- The influence of age, gender, and race on the prevalence of depression in heart failure patientsJournal of the American College of Cardiology, 2004
- The association between disease severity, functional status, depression and daily quality of life in congestive heart failure patientsQuality of Life Research, 2004
- Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failureJournal of the American College of Cardiology, 2003
- Depressive Symptoms and Health-Related Quality of LifeJAMA, 2003
- Depression and Major Outcomes in Older Patients With Heart FailureArchives of internal medicine (1960), 2002
- Relationship of Depression to Increased Risk of Mortality and Rehospitalization in Patients With Congestive Heart FailureArchives of internal medicine (1960), 2001
- Depressive symptoms and risk of functional decline and death in patients with heart failureJournal of the American College of Cardiology, 2001
- Prevalence of depression in congestive heart failureThe American Journal of Cardiology, 1999
- Depression in hospitalized older patients with congestive heart failureGeneral Hospital Psychiatry, 1998